In this
American Society of Health-System Pharmacists (ASHP) article,
Drug Counterfeiting Burden Remains a Guess, Experts Say, the Director of Pharmacy Affairs in FDA's Office of the Commissioner says, "We have no idea what the prevalence of counterfeiting is in the United States."
Here's what I get out of this article, counterfeiters have been assisted by the globalization of the pharmaceutical industry and a shift to making both active pharmaceutical ingredients (APIs) and finished products outside of the developed world.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.